How should I evaluate and manage a patient with a normal estimated glomerular filtration rate (eGFR) but an elevated serum creatinine?

Evaluation and Management of Normal eGFR with Elevated Creatinine

When you encounter a normal eGFR but elevated serum creatinine, this discrepancy signals that creatinine-based eGFR equations are likely inaccurate due to non-GFR determinants of creatinine, and you should immediately measure cystatin C to obtain a combined creatinine-cystatin C eGFR (eGFRcr-cys) for more accurate assessment. 1

Understanding the Discrepancy

The apparent contradiction between "normal" eGFR and "elevated" creatinine occurs because:

• Serum creatinine is influenced by multiple non-GFR factors including muscle mass, age, sex, diet, certain medications, and chronic illness—meaning an elevated creatinine doesn't always reflect reduced kidney function 1
• eGFR equations systematically adjust for these factors, which can normalize the calculated eGFR even when creatinine appears elevated 1
• Creatinine-based eGFR equations frequently overestimate true GFR, particularly in patients with preserved renal function, with studies showing biases of 20+ mL/min/1.73 m² 2, 3, 4

Immediate Diagnostic Steps

1. Measure Cystatin C

Order serum cystatin C on the same blood sample used for creatinine measurement to calculate eGFRcr-cys, which provides superior accuracy compared to creatinine alone 1:

• The combined creatinine-cystatin C equation improves precision (interquartile range 13.4 vs 15.4 mL/min/1.73 m²) and accuracy (8.5% vs 12.8% of estimates >30% off measured GFR) 5
• Cystatin C is independent of muscle mass, making it particularly valuable when muscle mass abnormalities may confound creatinine 1, 6
• In patients with eGFRcr 45-59 mL/min/1.73 m² without albuminuria, cystatin C correctly reclassifies 16.9% as having eGFR ≥60 mL/min/1.73 m² 1

2. Assess for Non-GFR Determinants of Creatinine

Systematically evaluate factors that elevate creatinine independent of kidney function 1:

• High muscle mass: Athletes, bodybuilders, manual laborers
• Dietary factors: Recent high meat intake, creatine supplementation
• Medications: Trimethoprim, cimetidine, fenofibrate (inhibit tubular secretion)
• Laboratory interference: Hyperbilirubinemia with colorimetric assays, ketoacidosis 1
• Acute increases: Recent strenuous exercise, rhabdomyolysis

3. Check Urine Albumin-to-Creatinine Ratio (ACR)

Obtain urine ACR to assess for kidney damage markers, as kidney disease can exist with normal GFR if albuminuria is present 1:

• Test both urine albumin and eGFR together, as recommended by KDIGO 2024 1
• Repeat abnormal results to confirm chronicity (≥3 months) 1
• Exclude transient causes: menstrual contamination, symptomatic UTI, recent exercise, upright posture 1

When to Measure GFR Directly

Consider measured GFR (mGFR) using exogenous filtration markers when accurate GFR assessment will change management 1:

Specific Indications for mGFR 1:

• Kidney donor candidacy evaluation
• Chemotherapy dosing with narrow therapeutic index drugs
• Simultaneous liver-kidney transplant decisions
• Suspected inaccuracy of eGFRcr-cys due to:
  • Extreme body habitus (BMI >40 kg/m²)
  • Severe catabolic states (advanced cirrhosis, heart failure, high-dose steroids)
  • Hematologic malignancies with high cell turnover

Clinical Decision Algorithm

If eGFRcr-cys Confirms Normal Kidney Function (≥60 mL/min/1.73 m²):

• The elevated creatinine likely reflects non-GFR determinants 1, 5
• No CKD diagnosis if ACR is also normal (<30 mg/g) 1
• Repeat testing in 3 months if clinical suspicion remains 1
• Document the specific non-GFR factor (e.g., "elevated creatinine due to high muscle mass, eGFRcr-cys normal")

If eGFRcr-cys Shows Reduced Function (<60 mL/min/1.73 m²):

• Diagnose CKD and stage appropriately 1
• Establish chronicity by reviewing past measurements or repeating in 3 months 1
• Initiate CKD evaluation: imaging (renal ultrasound), establish cause, assess for complications 1
• Monitor annually with both eGFR and ACR 1

If Large Discrepancy Persists Between eGFRcr and eGFRcys:

• The direction and magnitude of discrepancy may be informative 1
• Consider mGFR if high-stakes decisions depend on precise GFR knowledge 1
• Use timed urine creatinine clearance only if mGFR unavailable and eGFRcr-cys thought inaccurate 1

Critical Pitfalls to Avoid

• Never rely on serum creatinine alone without calculating eGFR—this is the fundamental error 1
• Don't assume chronicity from a single measurement—could represent acute kidney injury or acute kidney disease 1
• Don't confuse hemodynamic creatinine increases (<30% rise) with AKI when starting ACE inhibitors or ARBs—these are acceptable and should not prompt drug discontinuation 1
• Avoid using MDRD or Cockcroft-Gault equations—CKD-EPI equations are more accurate, and EKFC equations perform better in European populations 1, 6
• Don't overlook that all eGFR equations overestimate true GFR in patients with preserved renal function, with systematic biases of 20+ mL/min/1.73 m² 2, 3, 4

Laboratory Standards

Ensure your laboratory meets quality standards 1:

• Uses enzymatic creatinine assays (not Jaffe method) calibrated to IDMS reference materials
• Measures cystatin C with assays traceable to international reference materials
• Separates serum from red blood cells within 12 hours of venipuncture
• Reports eGFR automatically with creatinine results, flagging values <60 mL/min/1.73 m²